Review Immunotherapies for POTS, Other Common Autonomic Disorders and Long COVID: Current State and Future Direction, 2025, Blitshteyn et al

Discussion in 'Long Covid research' started by hotblack, Apr 17, 2025.

  1. hotblack

    hotblack Senior Member (Voting Rights)

    Messages:
    636
    Location:
    UK
    Immunotherapies for Postural Orthostatic Tachycardia Syndrome, Other Common Autonomic Disorders and Long COVID: Current State and Future Direction

    Blitshteyn, S., Funez-dePagnier, G., Szombathy, A., & Hutchinson, M

    Abstract
    Postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope, and orthostatic hypotension are the most common autonomic disorders encountered in clinical practice. Autoimmune etiology and association of these conditions with systemic autoimmune and inflammatory disorders, autonomic neuropathy and post-acute infectious syndromes, including Long COVID, suggest that immunotherapies should be considered as a therapeutic option, at least in a subset of patients.

    However, treatment of common autonomic disorders has traditionally included pharmacologic and non-pharmacologic symptomatic therapies as the standard approach. Unfortunately, these symptomatic therapies have been of limited or insufficient efficacy to meaningfully improve functional status or result in recovery, especially in patients with severe symptomatology.

    Case reports, case series, and clinical experience suggest that intravenous and subcutaneous immunoglobulin as well as other immunologic therapies, such as plasmapheresis, corticosteroids and rituximab, may be effective in some patients with severe POTS and other common autonomic disorders who are refractory to standard therapies.

    In this review, we summarize the literature available on the topic of immunotherapies in POTS, other common autonomic disorders, and Long COVID. We also highlight the need for large, multi-center, placebo-controlled trials of immunoglobulin, plasmapheresis, intermittent corticosteroids and other repurposed immunotherapies in patients with common autonomic disorders who have significant functional impairment.

    https://www.preprints.org/manuscript/202504.1175/v1 (preprints) [not peer-reviewed]

    doi: 10.20944/preprints202504.1175.v1
    https://doi.org/10.20944/preprints202504.1175.v1 (link not currently working)
     
    Last edited: Apr 17, 2025
    Peter Trewhitt likes this.
  2. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    2,411
    Links not working for me.
     
    Peter Trewhitt and hotblack like this.
  3. hotblack

    hotblack Senior Member (Voting Rights)

    Messages:
    636
    Location:
    UK
    Sorry about that, I messed up the first link. Fixed now
    The DOI link doesn’t seem to be working, but is as quoted in the citations, so will leave it and hope it starts to work at some point…
     
    Peter Trewhitt likes this.

Share This Page